Authors' reply to Mosholder and colleagues
Author(s) -
Christine Y. Lu,
Gregory E. Simon,
Stephen B. Soumerai
Publication year - 2014
Publication title -
bmj
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.831
H-Index - 429
ISSN - 1756-1833
DOI - 10.1136/bmj.g6516
Subject(s) - antidepressant , psychiatry , publicity , depression (economics) , mental health , mood , intervention (counseling) , medicine , psychology , political science , anxiety , law , economics , macroeconomics
We are glad that Mosholder and colleagues agree that psychotropic poisonings increased, not decreased, after the warnings and news reports.1 2 We believe that debate in this area is instructive for all those looking at nationwide health policies that cannot be studied using randomised controlled trials.3As discussed in the online comments, Mosholder and colleagues mis-state our conclusion. We did not conclude that “antidepressant warnings discouraged appropriate pharmacotherapy for depression.” We stated repeatedly in the article and National Institute of Mental Health proposal that the most important intervention was the alarming worldwide publicity that exaggerated the FDA warnings. This was immediately accompanied by reductions in antidepressant use (as corroborated by Mosholder and colleagues’ older data), small increases in suicide attempts by psychotropic drug poisoning (possibly owing to undertreatment of mood …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom